Issue: October 2016
October 04, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Rayner purchases Moorfields Pharmaceuticals
Issue: October 2016
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Moorfields Pharmaceuticals has been purchased from Moorfields Eye Hospital NHS Foundation Trust by Rayner.
Rayner is planning to launch a specialist ophthalmic pharmaceuticals division, expanding its European presence, and bought Moorfields for an undisclosed price in order to accomplish this, according to a press release from Rayner.
“[T]he acquisition of Moorfields Pharmaceuticals will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient,” Rayner CEO Tim Clover said in the release.
Moorfields Pharmaceuticals employees will continue to be based in London but will transfer to Rayner.